1
|
Stewart W and Wild P: World Cancer Report
2014. IARC Press; Lyon, France: 2015
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Shadfan A, Hellebust A, Richards-Kortum R
and Tkaczyk T: Confocal foveated endomicroscope for the detection
of esophageal carcinoma. Biomed Opt Express. 6:2311–2324. 2015.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Wang S, Du Z, Luo J, Wang X, Li H, Liu Y,
Zhang Y, Ma J, Xiao W, Wang Y and Zhong X: Inhibition of heat shock
protein 90 suppresses squamous carcinogenic progression in a mouse
model of esophageal cancer. J Cancer Res Clin Oncol. 141:1405–1416.
2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
6
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yue J and Tigyi G: Conservation of
miR-15a/16-1 and miR-15b/16-2 clusters. Mamm Genome. 21:88–94.
2010. View Article : Google Scholar :
|
8
|
Chan WC, Ho MR, Li SC, Tsai KW, Lai CH,
Hsu CN and Lin WC: MetaMirClust: Discovery of miRNA cluster
patterns using a data-mining approach. Genomics. 100:141–148. 2012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Olive V, Li Q and He L: miR-17-92: A
polycistronic oncomir with pleiotropic functions. Immunol Rev.
253:158–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mohan S, Wergedal JE, Das S and Kesavan C:
Conditional disruption of miR17-92 cluster in collagen type
I-producing osteoblasts results in reduced periosteal bone
formation and bone anabolic response to exercise. Physiol Genomics.
47:33–43. 2015. View Article : Google Scholar :
|
11
|
Luo T, Cui S, Bian C and Yu X: Crosstalk
between TGF-β/Smad3 and BMP/BMPR2 signaling pathways via miR-17-92
cluster in carotid artery restenosis. Mol Cell Biochem.
389:169–176. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Brockway S and Zeleznik-Le NJ: WEE1 is a
validated target of the microRNA miR-17-92 cluster in leukemia.
Cancer Genet. 208:279–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Bazot Q, Paschos K, Skalska L,
Kalchschmidt JS, Parker GA and Allday MJ: Epsteinbarr virus
proteins EBNA3A and EBNA3C together induce expression of the
oncogenic MicroRNA cluster miR-221/miR-222 and ablate expression of
its target p57KIP2. PLoS Pathog. 11:e10050312015. View Article : Google Scholar
|
14
|
Zhu H, Han C, Lu D and Wu T: miR-17-92
cluster promotes cholangiocarcinoma growth: Evidence for PTEN as
downstream target and IL-6/Stat3 as upstream activator. Am J
Pathol. 184:2828–2839. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Besser J, Malan D, Wystub K, Bachmann A,
Wietelmann A, Sasse P, Fleischmann BK, Braun T and Boettger T:
MiRNA-1/133a clusters regulate adrenergic control of cardiac
repolarization. PloS One. 9:e1134492014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gits CM, van Kuijk PF, Jonkers MB, Boersma
AW, Smid M, van Ijcken WF, Coindre JM, Chibon F, Verhoef C,
Mathijssen RH, et al: MicroRNA expression profiles distinguish
liposarcoma subtypes and implicate miR-145 and miR-451 as tumor
suppressors. Int J Cancer. 135:348–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Li Y, Li W, Ying Z, Tian H, Zhu X, Li J
and Li M: Metastatic heterogeneity of breast cancer cells is
associated with expression of a heterogeneous TGFβ-activating
miR424-503 gene cluster. Cancer Res. 74:6107–6118. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Wystub K, Besser J, Bachmann A, Boettger T
and Braun T: miR-1/133a clusters cooperatively specify the
cardiomyogenic lineage by adjustment of myocardin levels during
embryonic heart development. PLoS Genet. 9:e10037932013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yang M, Liu R, Sheng J, Liao J, Wang Y,
Pan E, Guo W, Pu Y and Yin L: Differential expression profiles of
microRNAs as potential biomarkers for the early diagnosis of
esophageal squamous cell carcinoma. Oncol Rep. 29:169–176.
2013.
|
20
|
Liu L, Wang S, Chen R, Wu Y, Zhang B,
Huang S, Zhang J, Xiao F, Wang M and Liang Y: Myc induced
miR-144/451 contributes to the acquired imatinib resistance in
chronic myelogenous leukemia cell K562. Biochem Biophys Res Commun.
425:368–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang X, Zhu H, Zhang X, Liu Y, Chen J,
Medvedovic M, Li H, Weiss MJ, Ren X and Fan GC: Loss of the
miR-144/451 cluster impairs ischaemic preconditioning-mediated
cardioprotection by targeting Rac-1. Cardiovasc Res. 94:379–390.
2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zang WQ, Yang X, Wang T, Wang YY, Du YW,
Chen XN, Li M and Zhao GQ: MiR-451 inhibits proliferation of
esophageal carcinoma cell line EC9706 by targeting CDKN2D and
MAP3K1. World J Gastroenterol. 21:5867–5876. 2015.PubMed/NCBI
|
23
|
Wang T, Zang WQ, Li M, Wang N, Zheng YL
and Zhao GQ: Effect of miR-451 on the biological behavior of the
esophageal carcinoma cell line EC9706. Dig Dis Sci. 58:706–714.
2013. View Article : Google Scholar
|
24
|
Xie Z, Chen G, Zhang X, Li D, Huang J,
Yang C, Zhang P, Qin Y, Duan Y, Gong B and Li Z: Salivary microRNAs
as promising biomarkers for detection of esophageal cancer. PloS
One. 8:e575022013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Jiang X, Shan A, Su Y, Cheng Y, Gu W, Wang
W, Ning G and Cao Y: miR-144/451 promote cell proliferation via
targeting PTEN/AKT pathway in insulinomas. Endocrinology.
156:2429–2439. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Rice TW, Blackstone EH and Rusch VW: 7th
Edition of the AJCC cancer staging manual: Esophagus and
esophagogastric junction. Ann Surg Oncol. 17:1721–1724. 2010.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)). Method. 25:402–408. 2001. View Article : Google Scholar
|
28
|
Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek
SH and Kim VN: MicroRNA genes are transcribed by RNA polymerase II.
EMBO J. 23:4051–4060. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du
ZW and Zhang JW: Human microRNA clusters: Genomic organization and
expression profile in leukemia cell lines. Biochem Biophys Res
Commun. 349:59–68. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Tian Y, Pan Q, Shang Y, Zhu R, Ye J, Liu
Y, Zhong X, Li S, He Y, Chen L, et al: MicroRNA-200 (miR-200)
cluster regulation by achaete scute-like 2 (Ascl2): Impact on the
epithelial-mesenchymal transition in colon cancer cells. J Biol
Chem. 289:36101–36115. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu
WT, Jegga AG and Fan GC: Synergistic effects of the GATA-4-mediated
miR-144/451 cluster in protection against simulated
ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell
Cardiol. 49:841–850. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Turczynska KM, Bhattachariya A, Säll J,
Göransson O, Swärd K, Hellstrand P and Albinsson S:
Stretch-sensitive down-regulation of the miR-144/451 cluster in
vascular smooth muscle and its role in AMP-activated protein kinase
signaling. PloS One. 8:e651352013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Fukumoto I, Kinoshita T, Hanazawa T,
Kikkawa N, Chiyomaru T, Enokida H, Yamamoto N, Goto Y, Nishikawa R,
Nakagawa M, et al: Identification of tumour suppressive
microRNA-451a in hypopharyngeal squamous cell carcinoma based on
microRNA expression signature. Br J Cancer. 111:386–394. 2014.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Moreira FC, Assumpção M, Hamoy IG, Darnet
S, Burbano R, Khayat A, Gonçalves AN, Alencar DO, Cruz A, Magalhães
L, et al: MiRNA expression profile for the human gastric antrum
region using ultra-deep sequencing. PloS One. 9:e923002014.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Ouyang M, Li Y, Ye S, Ma J, Lu L, Lv W,
Chang G, Li X, Li Q, Wang S and Wang W: MicroRNA profiling implies
new markers of chemoresistance of triple-negative breast cancer.
PloS One. 9:e962282014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Babapoor S, Fleming E, Wu R and Dadras SS:
A novel miR-451a isomiR, associated with amelanotypic phenotype,
acts as a tumor suppressor in melanoma by retarding cell migration
and invasion. PloS One. 9:e1075022014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Li M, Song Q, Li H, Lou Y and Wang L:
Circulating miR-25-3p and miR-451a may be potential biomarkers for
the diagnosis of papillary thyroid carcinoma. PloS One.
10:e01324032015. View Article : Google Scholar : PubMed/NCBI
|
38
|
Liu Z, Miao T, Feng T, Jiang Z, Li M, Zhou
L and Li H: miR-451a inhibited cell proliferation and enhanced
tamoxifen sensitive in breast cancer via macrophage migration
inhibitory factor. Biomed Res Int. 2015:2076842015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Katsuura S, Kuwano Y, Yamagishi N,
Kurokawa K, Kajita K, Akaike Y, Nishida K, Masuda K, Tanahashi T
and Rokutan K: MicroRNAs miR-144/144* and miR-16 in
peripheral blood are potential biomarkers for naturalistic stress
in healthy Japanese medical students. Neurosci Lett. 516:79–84.
2012. View Article : Google Scholar : PubMed/NCBI
|
40
|
Keller A, Leidinger P, Vogel B, Backes C,
ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick
R, et al: miRNAs can be generally associated with human pathologies
as exemplified for miR-144. BMC Med. 12:2242014. View Article : Google Scholar : PubMed/NCBI
|
41
|
Chen S, Li P, Li J, Wang Y, Du Y, Chen X,
Zang W, Wang H, Chu H, Zhao G and Zhang G: MiR-144 inhibits
proliferation and induces apoptosis and autophagy in lung cancer
cells by targeting TIGAR. Cell Physiol Biochem. 35:997–1007. 2015.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Guan H, Liang W, Xie Z, Li H, Liu J, Liu
L, Xiu L and Li Y: Down-regulation of miR-144 promotes thyroid
cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine.
48:566–574. 2015. View Article : Google Scholar
|
43
|
Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang
Z, Qiu F and Lin J: miR-144 downregulation increases bladder cancer
cell proliferation by targeting EZH2 and regulating Wnt signaling.
FEBS J. 280:4531–4538. 2013. View Article : Google Scholar : PubMed/NCBI
|
44
|
Matsushita R, Seki N, Chiyomaru T,
Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S,
Itesako T, et al: Tumour-suppressive microRNA-144-5p directly
targets CCNE1/2 as potential prognostic markers in bladder cancer.
Br J Cancer. 113:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
45
|
Omura T, Shimada Y, Nagata T, Okumura T,
Fukuoka J, Yamagishi F, Tajika S, Nakajima S, Kawabe A and Tsukada
K: Relapse-associated microRNA in gastric cancer patients after S-1
adjuvant chemotherapy. Oncol Rep. 31:613–618. 2014.
|
46
|
Pouladi N, Kouhsari SM, Feizi MH, Gavgani
RR and Azarfam P: Overlapping region of p53/Wrap53 transcripts:
Mutational analysis and sequence similarity with microRNA-4732-5p.
Asian Pac J Cancer Prev. 14:3503–3507. 2013. View Article : Google Scholar : PubMed/NCBI
|
47
|
Wu J, Bao J, Kim M, Yuan S, Tang C, Zheng
H, Mastick GS, Xu C and Yan W: Two miRNA clusters, miR-34b/c and
miR-449, are essential for normal brain development, motile
ciliogenesis, and spermatogenesis. Proc Natl Acad Sci USA.
111:E2851–E2857. 2014. View Article : Google Scholar : PubMed/NCBI
|